References
1. Armstrong GT, Chen Y, Yasui Y, et al. Reduction in Late Mortality
among 5-Year Survivors of Childhood Cancer. N Engl J Med
2016:374(9):833-842.
2. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer:
life-long risks and responsibilities. Nat Rev Cancer 2014:14(1):61-70.
3. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions
in adult survivors of childhood cancer. N Engl J Med
2006:355(15):1572-1582.
4. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of
health outcomes among adults treated for childhood cancer. JAMA
2013:309(22):2371-2381.
5. Turcotte LM, Yingst A, Verneris MR. Metabolic Syndrome after
Hematopoietic Cell Transplantation: At the Intersection of Treatment
Toxicity and Immune Dysfunction. Biol Blood Marrow Transplant
2016:22(7):1159-1166.
6. Oudin C, Auquier P, Bertrand Y, et al. Metabolic syndrome in adults
who received hematopoietic stem cell transplantation for acute childhood
leukemia: an LEA study. Bone Marrow Transplant 2015:50(11):1438-1444.
7. Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome
in adult survivors of childhood cancer: a report from the St. Jude
Lifetime Cohort Study. Cancer 2014:120(17):2742-2750.
8. Rosen GP, Nguyen HT, Shaibi GQ. Metabolic syndrome in pediatric
cancer survivors: a mechanistic review. Pediatr Blood Cancer
2013:60(12):1922-1928.
9. Paris C, Yates L, Lama P, et al. Evaluation of metabolic syndrome
after hematopoietic stem cell transplantation in children and
adolescents. Pediatr Blood Cancer 2012:59(2):306-310.
10. Baker KS, Chow E, Steinberger J. Metabolic syndrome and
cardiovascular risk in survivors after hematopoietic cell
transplantation. Bone Marrow Transplant 2012:47(5):619-625.
11. Oudin C, Simeoni MC, Sirvent N, et al. Prevalence and risk factors
of the metabolic syndrome in adult survivors of childhood leukemia.
Blood 2011:117(17):4442-4448.
12. van Waas M, Neggers SJ, Pieters R, et al. Components of the
metabolic syndrome in 500 adult long-term survivors of childhood cancer.
Ann Oncol 2010:21(5):1121-1126.
13. de Haas EC, Oosting SF, Lefrandt JD, et al. The metabolic syndrome
in cancer survivors. Lancet Oncol 2010:11(2):193-203.
14. Majhail NS, Flowers ME, Ness KK, et al. High prevalence of metabolic
syndrome after allogeneic hematopoietic cell transplantation. Bone
Marrow Transplant 2009:43(1):49-54.
15. Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors
of childhood cancer have an increased risk of manifesting the metabolic
syndrome. J Clin Endocrinol Metab 1996:81(8):3051-3055.
16. Monteiro R, Azevedo I. Chronic inflammation in obesity and the
metabolic syndrome. Mediators Inflamm 2010:2010.
17. Ariffin H, Azanan MS, Abd Ghafar SS, et al. Young adult survivors of
childhood acute lymphoblastic leukemia show evidence of chronic
inflammation and cellular aging. Cancer 2017:123(21):4207-4214.
18. Chua LL, Rajasuriar R, Azanan MS, et al. Reduced microbial diversity
in adult survivors of childhood acute lymphoblastic leukemia and
microbial associations with increased immune activation. Microbiome
2017:5(1):35.
19. Rotz SJ, Dandoy CE. The microbiome in pediatric oncology. Cancer
2020.
20. Chua LL, Rajasuriar R, Lim YAL, et al. Temporal changes in gut
microbiota profile in children with acute lymphoblastic leukemia prior
to commencement-, during-, and post-cessation of chemotherapy. BMC
Cancer 2020:20(1):151.
21. Hakim H, Dallas R, Wolf J, et al. Gut Microbiome Composition
Predicts Infection Risk During Chemotherapy in Children With Acute
Lymphoblastic Leukemia. Clin Infect Dis 2018:67(4):541-548.
22. Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven
dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther
2015:42(5):515-528.
23. Gasparrini AJ, Wang B, Sun X, et al. Persistent metagenomic
signatures of early-life hospitalization and antibiotic treatment in the
infant gut microbiota and resistome. Nat Microbiol 2019:4(12):2285-2297.
24. Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is
related to lifetime antibiotic use in Finnish pre-school children. Nat
Commun 2016:7:10410.
25. Yassour M, Vatanen T, Siljander H, et al. Natural history of the
infant gut microbiome and impact of antibiotic treatment on bacterial
strain diversity and stability. Sci Transl Med 2016:8(343):343ra381.
26. Saari A, Virta LJ, Sankilampi U, et al. Antibiotic exposure in
infancy and risk of being overweight in the first 24 months of life.
Pediatrics 2015:135(4):617-626.
27. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome
in obese and lean twins. Nature 2009:457(7228):480-484.
28. Sun S, Lulla A, Sioda M, et al. Gut Microbiota Composition and Blood
Pressure. Hypertension 2019:73(5):998-1006.
29. Org E, Blum Y, Kasela S, et al. Relationships between gut
microbiota, plasma metabolites, and metabolic syndrome traits in the
METSIM cohort. Genome Biol 2017:18(1):70.
30. Green DM, Nolan VG, Goodman PJ, et al. The cyclophosphamide
equivalent dose as an approach for quantifying alkylating agent
exposure: a report from the Childhood Cancer Survivor Study. Pediatr
Blood Cancer 2014:61(1):53-67.
31. Sinha R, Abnet CC, White O, et al. The microbiome quality control
project: baseline study design and future directions. Genome biology
2015:16:276.
32. Hall M, Beiko RG. 16S rRNA Gene Analysis with QIIME2. Methods Mol
Biol 2018:1849:113-129.
33. Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: High-resolution
sample inference from Illumina amplicon data. Nat Methods
2016:13(7):581-583.
34. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible
interactive analysis and graphics of microbiome census data. PLoS One
2013:8(4):e61217.
35. Beals EW. Bray-Curtis Ordination: An Effective Strategy for Analysis
of Multivariate Ecological Data. In: MacFadyen A, Ford ED, editors.
Advances in Ecological Research. Volume 14: Academic Press; 1984. p
1-55.
36. Wickham H. ggplot2: Elegant Graphics for Data Analysis: Springer
Publishing Company, Incorporated; 2009. 216 p.
37. White JR, Nagarajan N, Pop M. Statistical methods for detecting
differentially abundant features in clinical metagenomic samples. PLoS
Comput Biol 2009:5(4):e1000352.
38. Hochberg Y, Benjamini Y. More powerful procedures for multiple
significance testing. Stat Med 1990:9(7):811-818.
39. Cozen W, Yu G, Gail MH, et al. Fecal microbiota diversity in
survivors of adolescent/young adult Hodgkin lymphoma: a study of twins.
Br J Cancer 2013:108(5):1163-1167.
40. Reis Ferreira M, Andreyev HJN, Mohammed K, et al. Microbiota- and
Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large
Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy.
Clin Cancer Res 2019:25(21):6487-6500.
41. Sahly N, Moustafa A, Zaghloul M, et al. Effect of radiotherapy on
the gut microbiome in pediatric cancer patients: a pilot study. PeerJ
2019:7:e7683.
42. Huseyin CE, O’Toole PW, Cotter PD, et al. Forgotten fungi-the gut
mycobiome in human health and disease. FEMS Microbiol Rev
2017:41(4):479-511.
43. Mar Rodriguez M, Perez D, Javier Chaves F, et al. Obesity changes
the human gut mycobiome. Sci Rep 2015:5:14600.